Human T Lymphocyte Genetic Modification with Naked DNA

Molecular Therapy

Volumn 1, Issue 1, 2000, Pages 49-55

  Jensen, Michael C ^a   Clarke, Patrick ^a   Tan, Giselle ^a   Wright, Christine ^a   Chung Chang, Wen ^a   Clark, Teresa N ^a   Zhang, Feiyu ^a   Slovak, Marilyn L ^a   Wu, Anna M ^a   Forman, Stephen J ^a   Raubitschek, Andrew ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

Immunotherapy; T cells; electroporation; plasmid vector

Indexed keywords

ANTIGEN T CELL RECEPTOR, ZETA CHAIN; HYBRID PROTEIN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL LINE; ELECTROPORATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; PLASMID;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CLONE CELLS; ELECTROPORATION; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; IN SITU HYBRIDIZATION, FLUORESCENCE; MEMBRANE PROTEINS; PLASMIDS; RECEPTORS, ANTIGEN, T-CELL; RECOMBINANT FUSION PROTEINS;

EID: 0033655529     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.1999.0012     Document Type: Article

References (34)

1. Riddell S. R., Watanabe K. S., Goodrich J. M., Li C. R., Agha M. E., Greenberg P. D. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones [see comments]. Science. 257:1992;238-241.
2. Walter E. A., Greenberg P. D., Gilbert M. J., Finch R. J., Watanabe K. S., Thomas E. D., Riddell S. R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor [see comments]. New Engl. J. Med. 333:1995;1038-1044.
3. Rooney C. M., Smith C. A., Ng C. Y., Loftin S. K., Sixbey J. W., Gan Y., Srivastava D. K., Bowman L. C., Krance R. A., Brenner M. K., Heslop H. E. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood. 92:1998;1549-1555.
4. Brodie S. J., Lewinsohn D. A., Patterson B. K., Jiyamapa D., Krieger J., Corey L., Greenberg P. D., Riddell S. R. In vivo migration and function of transferred HIV-1-specific cytotoxic T cells [see comments]. Nat. Med. 5:1999;34-41.
5. Rosenberg S. A. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity. 10:1999;281-287.
6. + T cells become nonresponsive (anergic) following activation in the presence of costimulation. J. Immunol. 163:1999;102-110.
7. Zaks T. Z., Chappell D. B., Rosenberg S. A., Restifo N. P. Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: Selective rescue by caspase inhibition. J. Immunol. 162:1999;3273-3279.
8. + CTL clones is limited by elimination due to encounter with HIV-infected targets. J. Immunol. 163:1999;861-867.
9. Greenberg P. D., Finch R. J., Gavin M. A., Kalos M., Lewinsohn D. A., Lonergan M., Lord J. D., Nelson B. H., Ohlen C., Sing A. P., Warren E. H., Yee C., Riddell S. R. Genetic modification of T-cell clones for therapy of human viral and malignant diseases [in process citation]. Cancer J. Sci. Am. 4:1998;S100-S105.
10. Beltinger C., Fulda S., Kammertoens T., Meyer E., Uckert W., Debatin K. M. Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases. Proc. Natl. Acad. Sci. USA. 96:1999;8699-8704.
11. Tiberghien P. "Suicide" gene for the control of graft-versus-host disease. Curr. Opin. Hematol. 5:1998;478-482.
12. Fox B. A., Woffendin C., Yang Z. Y., San H., Ranga U., Gordon D., Osterholzer J., Nabel G. J. Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: Safety and toxicity. Hum. Gene Ther. 6:1995;997-1004.
13. Morgan R. A., Walker R. Gene therapy for AIDS using retroviral mediated gene transfer to deliver HIV-1 antisense TAR and transdominant Rev protein genes to syngeneic lymphocytes in HIV-1 infected identical twins. Hum. Gene Ther. 7:1996;1281-1306.
14. Manca F., Fenoglio D., Franchin E., Saverino D., Li P. G., Buffa F., Bignardi D., Del Pup L., Palu G. Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS. Gene Ther. 4:1997;1216-1224.
15. Clay T. M., Custer M. C., Sachs J., Hwu P., Rosenberg S. A., Nishimura M. I. Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity. J. Immunol. 163:1999;507-513.
16. Altenschmidt U., Klundt E., Groner B. Adoptive transfer of in vitro-targeted, activated T lymphocytes results in total tumor regression. J. Immunol. 159:1997;5509-5515.
17. Brocker T., Karjalainen K. Adoptive tumor immunity mediated by lymphocytes bearing modified antigen-specific receptors. Adv. Immunol. 68:1998;257-269.
18. Hwu P., Rosenberg S. A. The genetic modification of T cells for cancer therapy: An overview of laboratory and clinical trials. Cancer Detect. Prev. 18:1994;43-50.
19. Hege K. M., Roberts M. R. T-cell gene therapy. Curr. Opin. Biotechnol. 7:1996;629-634.
20. Miller A. D. Retrovirus packaging cells. Hum. Gene Ther. 1:1990;5-14.
21. Miller A. D. Retroviral vectors. Curr. Top. Microbiol. Immunol. 158:1992;1-24.
22. + malignancy [in process citation]. Biol. Blood Marrow Transplant. 4:1998;75-83.
23. Bird A. G., McLachlan S. M., Britton S. Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature. 289:1981;300-301.
24. Sambrook J., Fritsch E. F., Maniatis T., Irwin N. Ford N., Nolan C., Ferguson M. Molecular Cloning: A Laboratory Manual. 1989;9.16-9.19 Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
25. Emerman M., Temin H. M. High-frequency deletion in recovered retrovirus vectors containing exogenous DNA with promoters. J. Virol. 50:1984;42-49.
26. Muenchau D. D., Freeman S. M., Cornetta K., Zwiebel J. A., Anderson W. F. Analysis of retroviral packaging lines for generation of replication-competent virus. Virology. 176:1990;262-265.
27. Varela-Echavarria A., Prorock C. M., Ron Y., Dougherty J. P. High rate of genetic rearrangement during replication of a Moloney murine leukemia virus-based vector. J. Virol. 67:1993;6357-6364.
28. Wang R., Doolan D. L., Le T. P., Hedstrom R. C., Coonan K. M., Charoenvit Y., Jones T. R., Hobart P., Margalith M., Ng J., Weiss W. R., Sedegah M., de Taisne C., Norman J. A., Hoffman S. L. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science. 282:1998;476-480.
29. Ugen K. E., Nyland S. B., Boyer J. D., Vidal C., Lera L., Rasheid S., Chattergoon M., Bagarazzi M. L., Ciccarelli R., Higgins T., Baine Y., Ginsberg R., Macgregor R. R., Weiner D. B. DNA vaccination with HIV-1 Expressing constructs elicits immune responses in humans. Vaccine. 16:1998;1818-1821.
30. Cotten M., Saltik M. Intracellular delivery of lipopolysaccharide during DNA transfection activates a lipid A-dependent cell death response that can be prevented by polymyxin B. Hum. Gene Ther. 8:1997;555-561.
31. Ebert O., Finke S., Salahi A., Herrmann M., Trojaneck B., Lefterova P., Wagner E., Kircheis R., Huhn D., Schriever F., Schmidt-Wolf I. G. Lymphocyte apoptosis: Induction by gene transfer techniques. Gene Ther. 4:1997;296-302.
32. Toneguzzo F., Hayday A. C., Keating A. Electric field-mediated DNA transfer: Transient and stable gene expression in human and mouse lymphoid cells. Mol. Cell Biol. 6:1986;703-706.
33. Ohtani K., Nakamura M., Saito S., Nagata K., Sugamura K., Hinuma Y. Electroporation: Application to human lymphoid cell lines for stable introduction of a transactivator gene of human T-cell leukemia virus type I. Nucleic Acids Res. 17:1989;1589-1604.
34. Gallot G., Hallet M. M., Gaschet J., Moreau J. F., Vivien R., Bonneville M., Milpied N., Vie H. Human HLA-specific T-cell clones with stable expression of a suicide gene: A possible tool to drive and control a graft-versus-host-graft-versus-leukemia reaction. Blood. 88:1996;1098-1103.